Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anebulo Pharmaceuticals Inc
(NQ:
ANEB
)
1.980
+0.040 (+2.06%)
Streaming Delayed Price
Updated: 3:44 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Anebulo Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
November 10, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
Lower Doses Of Anebulo's ANEB-001 Reduces Negative Effects Of Higher Doses Of THC
September 26, 2022
Via
Benzinga
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
December 06, 2022
Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...
Via
Benzinga
Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors
November 01, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
Anebulo's ANEB-001 Reduces Cannabis Intoxication In Healthy Participants
July 05, 2022
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
On Tuesday, 120 companies set new 52-week lows.
Via
Benzinga
Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session
October 25, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 03, 2022
Gainers
Via
Benzinga
Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing
September 26, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
October 18, 2022
During Tuesday's session, 78 companies made new 52-week lows.
Via
Benzinga
Anebulo Pharmaceuticals Announces Positive Interim Data for ANEB-001 from Part B of its Phase 2 Clinical Trial for Acute Cannabinoid Intoxication
September 26, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
October 04, 2022
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...
Via
Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
October 03, 2022
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
Via
Benzinga
Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022
September 20, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
Anebulo Pharma Posts FY 2022 Earnings, Positive Results From Clinical Trial For Treatment Of Acute Cannabinoid Intoxication
September 09, 2022
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse,...
Via
Benzinga
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress
September 09, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26
August 23, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022
July 27, 2022
Via
Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
July 15, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 14, 2022
Via
Benzinga
Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session
July 14, 2022
Gainers Shineco, Inc. (NASDAQ: SISI) shares climbed 24.5% to $1.2201 on heavy volume.
Via
Benzinga
Why U.S. Stocks Are Trading Lower; Tesla Shares Drop After Price Target Cut At JPMorgan
July 05, 2022
U.S. stocks traded sharply lower this morning, after the major indices closed another losing week. The Dow Jones gained around 200 points on Friday.
Via
Benzinga
Suffering From Acute Cannabinoid Intoxication? Anebulo Is Getting Closer To Investigational New Drug Application
July 05, 2022
Anebulo Pharmaceuticals, Inc.
Via
Benzinga
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
July 05, 2022
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 05, 2022
Via
Benzinga
Anebulo Shares Gain After Positive Topline Results From Mid-stage Study Of Cannabinoid Intoxication Candidate
July 05, 2022
Anebulo Pharmaceuticals (NASDAQ: ANEB) announced positive topline data from Part A of an ongoing Phase 2 clinical trial of its drug candidate ANEB-001 for patients with acute cannabinoid intoxication...
Via
Benzinga
Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication
July 05, 2022
From
Anebulo Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.